CN Patent
CN114907283B — 一种2-(3,5-二氯苯基)-苯并噁唑-6-羧酸的制备方法
Assigned to Nanjing Chia Tai Tianqing Pharmaceutical Co Ltd · Expires 2025-01-28 · 1y expired
What this patent protects
本发明提供了一种2‑(3,5‑二氯苯基)‑苯并噁唑‑6‑羧酸的制备方法。具体而言,通过溶剂的选择以及反应条件的优化,避免了中间体后处理的过程,更加绿色环保,更适合工业化。
USPTO Abstract
本发明提供了一种2‑(3,5‑二氯苯基)‑苯并噁唑‑6‑羧酸的制备方法。具体而言,通过溶剂的选择以及反应条件的优化,避免了中间体后处理的过程,更加绿色环保,更适合工业化。
Drugs covered by this patent
- Vyndaqel (Tafamidis Meglumine) · Foldrx Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.